Injective INJ
Current Price
$3.89 +3.53%
$0.1700 Daily Range (4.37%)
$3.75$3.92
$48.68M Daily Volume
598 BTC
Vol/MktCap: 12.52%
Market Performance
0.11% Relative BTC Volume
The total volume of Injective is $48.68M over the past 24 hours, compared to $42.79B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.88 +0.33%
13 SMA $3.88 +0.33%
21 SMA $3.86 +0.90%
55 SMA $3.78 +3.04%
144 SMA $3.72 +4.52%
Price Performance
+1.19% 1 Hour Change
$3.89 from $3.84
+12.12% 7 Day Change
$0.4715 from $3.42
+16.40% 14 Day Change
$0.6381 from $3.25
+34.96% 30 Day Change
$1.36 from $2.53
All Time High
March 14, 2024
$52.62 -92.60%
-$48.73 vs. now
24H Change
14.04M USD +3.74%
173 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
12.69M INJ
traded over past 24 hours
12.69% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.90, experiencing a 24-hour change of 2.58%. The daily trading range has been tight, with a high of $3.92 and a low of $3.75, indicating relatively stable price action within this period.
The trading volume stands at approximately 60.08 million, representing a volume-to-market cap ratio of 15.40%. This level of volume suggests a healthy trading environment, reflecting investor interest and engagement with INJ, which can support further price movements.
The hourly moving averages indicate a bullish trend, with the 8 SMA and 13 SMA both showing an increase of 0.58% at $3.88. Additionally, the longer-term moving averages, such as the 55 SMA and 144 SMA, demonstrate stronger gains of 3.30% and 4.79%, respectively, reinforcing the upward momentum.
The 1-hour RSI is at 57, suggesting that INJ is nearing overbought territory but still has room for further upward movement. Meanwhile, the 7-day and 14-day RSIs are at 58 and 17.45% price change, respectively, indicating sustained bullish sentiment over the short to medium term.
Over the past 30 days, INJ has increased by approximately 33.92%, showcasing strong performance and suggesting that market participants are confident in its continued growth potential. However, it remains significantly below its all-time high of $52.62 reached in March 2024, indicating substantial room for recovery.
Given the current technical indicators, bullish moving averages, and sustained upward price trends, the outlook for Injective (INJ) appears positive. Therefore, a Buy rating is warranted as the asset shows strong momentum and potential for further gains in the near term.
The trading volume stands at approximately 60.08 million, representing a volume-to-market cap ratio of 15.40%. This level of volume suggests a healthy trading environment, reflecting investor interest and engagement with INJ, which can support further price movements.
The hourly moving averages indicate a bullish trend, with the 8 SMA and 13 SMA both showing an increase of 0.58% at $3.88. Additionally, the longer-term moving averages, such as the 55 SMA and 144 SMA, demonstrate stronger gains of 3.30% and 4.79%, respectively, reinforcing the upward momentum.
The 1-hour RSI is at 57, suggesting that INJ is nearing overbought territory but still has room for further upward movement. Meanwhile, the 7-day and 14-day RSIs are at 58 and 17.45% price change, respectively, indicating sustained bullish sentiment over the short to medium term.
Over the past 30 days, INJ has increased by approximately 33.92%, showcasing strong performance and suggesting that market participants are confident in its continued growth potential. However, it remains significantly below its all-time high of $52.62 reached in March 2024, indicating substantial room for recovery.
Given the current technical indicators, bullish moving averages, and sustained upward price trends, the outlook for Injective (INJ) appears positive. Therefore, a Buy rating is warranted as the asset shows strong momentum and potential for further gains in the near term.
Updated 97 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

KelpDAO Slams Layerzero After $300M Exploit, Shifts rsETH to Chainlink CCIP
Following a $300 million exploit on April 18, 2026, KelpDAO has publicly challenged LayerZero Labs’ account of the incident, alleging that the bridge provider is deflecting blame…

Roobet Launches Prediction Markets on May 6, The First Major Crypto Casino to Integrate the Format
Los Angeles, United States, 6th May 2026,…

Ethereum price reclaims $2,380: Is ETH’s structural shift finally here?
The Ethereum rally beyond $2.4k, combined with strong Taker Buy Volume, suggested the current rally might extend higher.

Ethena, Kelp DAO diverge on root cause of $300M LayerZero exploit
Ethena and Kelp DAO have offered different views on the $300M LayerZero exploit, underscoring a broader debate on DeFi security models.